{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06433765",
            "orgStudyIdInfo": {
                "id": "TG1101-RMS403"
            },
            "organization": {
                "fullName": "TG Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study Evaluating the Effect of BRIUMVI\u00ae (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)",
            "officialTitle": "BRIUMVI\u00ae Pregnancy Registry: A Prospective Study of Pregnancy and Infant Outcomes in Patients Treated With BRIUMVI\u00ae",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-evaluating-the-effect-of-briumvi-ublituximab-on-pregnancy-and-infant-outcomes-in-participants-with-multiple-sclerosis-ms"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-23",
            "studyFirstSubmitQcDate": "2024-05-23",
            "studyFirstPostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "TG Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of the study is to compare the prevalence rate of major congenital malformations (MCM) between 2 cohorts of pregnant participants with MS who are exposed to BRIUMVI\u00ae and who are unexposed to BRIUMVI\u00ae."
        },
        "conditionsModule": {
            "conditions": [
                "Multiple Sclerosis"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 728,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "BRIUMVI\u00ae Exposed Cohort",
                    "description": "Pregnant participants with MS who are exposed to any dose of BRIUMVI\u00ae at any time during pregnancy (from conception to pregnancy outcome) or before pregnancy (within 6 months of the date of conception \\[DOC\\]).",
                    "interventionNames": [
                        "Other: No intervention"
                    ]
                },
                {
                    "label": "BRIUMVI\u00ae Unexposed Cohort",
                    "description": "Pregnant participants with MS who are not exposed to any dose of BRIUMVI\u00ae or other anti-CD20 monoclonal antibodies at any time during pregnancy but may be exposed to other products for the treatment of MS.",
                    "interventionNames": [
                        "Other: No intervention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "No intervention",
                    "description": "No intervention",
                    "armGroupLabels": [
                        "BRIUMVI\u00ae Exposed Cohort",
                        "BRIUMVI\u00ae Unexposed Cohort"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of Participants with Major Congenital Malformations (MCMs)",
                    "timeFrame": "Up to 52 weeks post-delivery"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. For exposed cohort: Participant exposed to at least 1 dose of BRIUMVI\u00ae.\n2. For unexposed cohort: Participants not exposed to BRIUMVI\u00ae at any time during the pregnancy.\n3. Diagnosis of MS.\n4. Currently or recently (within 1 year of pregnancy outcome) pregnant.\n5. Authorization from healthcare provider to provide data to registry.\n\nExclusion Criteria:\n\n1. Prior to enrollment, participant has exposure to anti-CD20 monoclonal antibodies at any time during pregnancy.\n2. Occurrence of pregnancy outcome prior to first contact with the virtual research coordination center (VRCC) (retrospectively enrolled).\n3. Exposure to known teratogens and/or investigational medications during pregnancy.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "minimumAge": "15 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ],
            "studyPopulation": "The study population will include pregnant participants with MS who are either exposed or not exposed to BRIUMVI\u00ae.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BRIUMVI\u00ae Pregnancy Registry Virtual Research Coordination Center",
                    "role": "CONTACT",
                    "phone": "1-877-411-4605",
                    "email": "briumvipregnancyregistry@ppd.com"
                },
                {
                    "name": "TG Therapeutics Clinical Support Team",
                    "role": "CONTACT",
                    "phone": "1-877-555-8489",
                    "email": "clinicalsupport@tgtxinc.com"
                }
            ],
            "locations": [
                {
                    "facility": "BRIUMVI\u00ae Pregnancy Registry Virtual Research Coordination Center",
                    "status": "RECRUITING",
                    "city": "Wilmington",
                    "state": "North Carolina",
                    "zip": "28401-3331",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.22573,
                        "lon": -77.94471
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009103",
                    "term": "Multiple Sclerosis"
                },
                {
                    "id": "D000012598",
                    "term": "Sclerosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000020278",
                    "term": "Demyelinating Autoimmune Diseases, CNS"
                },
                {
                    "id": "D000020274",
                    "term": "Autoimmune Diseases of the Nervous System"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000003711",
                    "term": "Demyelinating Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12060",
                    "name": "Multiple Sclerosis",
                    "asFound": "Multiple Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15415",
                    "name": "Sclerosis",
                    "asFound": "Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22098",
                    "name": "Demyelinating Autoimmune Diseases, CNS",
                    "relevance": "LOW"
                },
                {
                    "id": "M22094",
                    "name": "Autoimmune Diseases of the Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M6909",
                    "name": "Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M4230",
                    "name": "Antibodies, Monoclonal",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}